Congress trades
Repligen Corporation (RGEN)
Free on iOS and Android.
About Repligen Corporation
from the company's filings and listing, as of Oct 24, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Chief executive
- Olivier Loeillot
- Employees
- 2,000
- Listed since
- Apr 29, 1986
- Market value
- $11.2B
- Price to earnings (12 mo)
- 239.1
- Net income per share, as reported (12 mo)
- $0.74
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 27, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 28, 2026 | $0.54 | $0.45 | $204.1M | $201.6M | EPS beatRevenue in line |
| Q1 FY2026reported May 5, 2026 | $0.48 | $0.38 | $194.3M | $192.1M | EPS beatRevenue in line |
| Q4 FY2025reported Feb 24, 2026 | $0.49 | $0.44 | $197.9M | $192.9M | EPS beatRevenue beat |
| Q3 FY2025reported Oct 28, 2025 | $0.46 | $0.42 | $188.8M | $182.1M | EPS beatRevenue beat |
| Q2 FY2025reported Jul 29, 2025 | $0.37 | $0.40 | $182.4M | $175.2M | EPS missRevenue beat |
| Q1 FY2025reported Apr 29, 2025 | $0.39 | $0.35 | $169.2M | $163.7M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 2, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Olivier LoeillotPresident and Chief Executive Officer | $860K | $3.4M | $1.9M | $6.1M |
| Jason K. GarlandChief Financial Officer | $567K | $1.5M | $922K | $3.0M |
| James BylundChief Operating Officer | $481K | $1.6M | $862K | $2.9M |
| Ralf KuriyelSenior Vice President, Research and Development | $421K | $1.2M | $694K | $2.3M |
| Brian DouglassSenior Vice President, Chief Product Officer | $417K | $912K | $405K | $1.7M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $734.7M | 5,384,938 | -10.1% | 9.55% |
| FMR LLC | $453.9M | 3,326,690 | +15.2% | 5.90% |
| United Capital Financial Advisors, LLC | $380.8M | 2,790,650 | +0.6% | 4.95% |
| Vanguard Capital Management LLC | $329.0M | 2,411,171 | +0.6% | 4.28% |
| Vanguard Portfolio Management LLC | $315.6M | 2,312,825 | +0.3% | 4.10% |
| Maverick Capital Ltd | $270.8M | 1,984,554 | +30.7% | 3.52% |
| State Street Corp | $245.7M | 1,800,530 | +1.3% | 3.19% |
| T. Rowe Price Associates, Inc. | $239.1M | 1,752,274 | -64.1% | 3.11% |
| Massachusetts Financial Services Co | $220.6M | 1,617,021 | +15.7% | 2.87% |
| Wasatch Advisors LP | $217.0M | 1,590,251 | +27.9% | 2.82% |
| Ameriprise Financial Inc | $215.0M | 1,576,132 | +70.4% | 2.80% |
| Bank of New York Mellon Corp | $207.8M | 1,522,859 | -0.6% | 2.70% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Tracked fund managers holding RGEN
3 managers| Manager | Value | Shares | Share of book |
|---|---|---|---|
| Maverick CapitalLee Ainslie | $270.8M | 1,984,554 | 2.4% |
| Vestal Point Capital | $54.6M | 400,000 | 1.3% |
| Perceptive AdvisorsJoseph Edelman | $33.9M | 248,212 | 0.5% |
3 of the 97 fund managers we track list RGEN shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in RGEN
8 disclosures of 8 on record · median 22d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +22.4%After the saleS&P 500 +11.7% · +10.7 pts vs S&P 500 | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +22.4%S&P 500 +11.7% · +10.7 pts vs S&P 500 | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +18.7%After the saleS&P 500 +11.4% · +7.3 pts vs S&P 500 | Oct 31, 2025 | Nov 21, 2025 | 21d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +34.0%S&P 500 +26.4% · +7.7 pts vs S&P 500 | Jun 11, 2025 | Aug 13, 2025 | 63d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +46.2%After the saleS&P 500 +27.2% · +19.1 pts vs S&P 500 | Jun 17, 2025 | Aug 13, 2025 | 57d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +55.0%S&P 500 +20.9% · +34.2 pts vs S&P 500 | Jul 22, 2025 | Aug 13, 2025 | 22d |
| Jefferson Shreve | Stock | Sale | $15,001 - $50,000 | +52.4%After the saleS&P 500 +50.7% · +1.7 pts vs S&P 500 | Apr 7, 2025 | May 8, 2025 | 31d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -6.1%After the saleS&P 500 +70.1% · -76.2 pts vs S&P 500 | Jan 20, 2022 | Feb 8, 2022 | 19d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in RGEN, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded RGEN?
Lisa C. McClain, Jefferson Shreve and Ro Khanna disclosed RGEN transactions in the filings shown here.
How quickly are RGEN trades disclosed?
Congressional disclosures took a median of 22 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.